当前位置:首页 - 行情中心 - 科前生物(688526) - 财务分析 - 现金流量表

科前生物

(688526)

  

流通市值:53.46亿  总市值:53.46亿
流通股本:4.66亿   总股本:4.66亿

现金流量表

报告期2026-09-302026-06-302026-03-312025-12-31
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金609,874,405.6377,419,436.82219,745,519.68904,601,039.08
  收到其他与经营活动有关的现金20,615,698.1916,724,534.263,566,776.7441,495,964.45
  经营活动现金流入小计630,490,103.79394,143,971.08223,312,296.42946,097,003.53
  购买商品、接受劳务支付的现金36,997,377.6116,909,664.5914,918,179.2183,684,820.36
  支付给职工以及为职工支付的现金140,896,980.35105,485,795.8571,660,010.93195,371,574.78
  支付的各项税费103,052,419.1476,318,231.6747,518,647.0191,770,563.98
  支付其他与经营活动有关的现金123,472,282.0879,573,832.5938,743,895.97106,728,211.19
  经营活动现金流出小计404,419,059.18278,287,524.7172,840,733.12477,555,170.31
  经营活动产生的现金流量净额226,071,044.61115,856,446.3850,471,563.3468,541,833.22
二、投资活动产生的现金流量:
  收回投资收到的现金2,749,309,746.921,929,659,552.141,058,250,245.061,332,193,679.14
  取得投资收益收到的现金51,754,534.4434,946,985.3213,615,479.2878,521,041.75
  处置固定资产、无形资产和其他长期资产收回的现金净额---7,754,731.68
  收到的其他与投资活动有关的现金12,066,446.0511,196,528.17--
  投资活动现金流入小计2,813,130,727.411,975,803,065.631,071,865,724.341,418,469,452.57
  购建固定资产、无形资产和其他长期资产支付的现金45,896,393.3835,573,069.9413,992,054.49123,878,027.06
  投资支付的现金2,724,044,826.531,758,739,0001,085,990,0001,938,983,793.33
  取得子公司及其他营业单位支付的现金---4,500,000
  支付其他与投资活动有关的现金4,838,463.924,662,411.03--
  投资活动现金流出小计2,774,779,683.831,798,974,480.971,099,982,054.492,067,361,820.39
  投资活动产生的现金流量净额38,351,043.58176,828,584.66-28,116,330.15-648,892,367.82
三、筹资活动产生的现金流量:
  收到其他与筹资活动有关的现金---17,692,584
  筹资活动现金流入平衡项目---0
  筹资活动现金流入小计---17,692,584
  分配股利、利润或偿付利息支付的现金298,560,125.65298,560,125.65-199,484,087.69
  支付其他与筹资活动有关的现金10,337,913.02967,287.26576,250.382,478,289.41
  筹资活动现金流出小计308,898,038.67299,527,412.91576,250.38201,962,377.1
  筹资活动产生的现金流量净额-308,898,038.67-299,527,412.91-576,250.38-184,269,793.1
四、汇率变动对现金及现金等价物的影响-3,533.47-15,970.82-9,243.55-2,056,879.58
五、现金及现金等价物净增加额-44,479,483.95-6,858,352.6921,769,739.22-366,677,207.28
  加:期初现金及现金等价物余额176,801,385.46176,801,385.46176,801,385.46543,478,592.74
  期末现金及现金等价物余额132,321,901.51169,943,032.77198,571,124.68176,801,385.46
补充资料:
  净利润-114,723,822.66-416,941,266.13
  资产减值准备-8,642,244.07-12,636,565.86
  固定资产和投资性房地产折旧-60,038,188.45-107,523,702.65
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-60,038,188.45-107,523,702.65
  无形资产摊销-2,064,324.38-4,241,254.21
  长期待摊费用摊销-242,373.42-479,141.3
  处置固定资产、无形资产和其他长期资产的损失-1,895,027.12-6,896,508.3
  固定资产报废损失---508,769.61
  公允价值变动损失--18,336,038.27--33,271,389.35
  财务费用--18,492,011.08--44,499,804.47
  投资损失--4,523,727.69--7,405,727.22
  递延所得税-4,886,330.32-537,541.07
  其中:递延所得税资产减少-124,344.14-457,988.48
    递延所得税负债增加-4,761,986.18-79,552.59
  存货的减少--14,942,008.76--30,953,325.53
  经营性应收项目的减少-18,014,511.46-54,547,824.63
  经营性应付项目的增加--43,547,377.93--16,268,050.74
  其他---4,831,281.82
  融资租入固定资产---895,040.65
  现金的期末余额-169,943,032.77-176,801,385.46
  减:现金的期初余额-176,801,385.46-543,478,592.74
  现金及现金等价物的净增加额--6,858,352.69--366,677,207.28
公告日期2026-10-312026-08-272026-04-302026-04-08
审计意见(境内)标准无保留意见
TOP↑